FIU Discovery

Ethnicity and race as modifiers of the association between patient sex and stage at diagnosis of bladder cancer.  CANCER EPIDEMIOLOGY.  95.

Ethnic disparities in clinical trials for FDA-approved drugs in urothelial cancer: An analysis in the post-COVID-19 era (2020-2024)..  JOURNAL OF CLINICAL ONCOLOGY.  43:677-677.

Durability of response of UGN-101: Longitudinal follow up of multicenter study.  UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 

PD41-11 LONGITUDINAL FOLLOW UP OF MULTICENTER STUDY OF UGN-101 FOR UPPER TRACT UROTHELIAL CANCER

PD41-12 EXPLORING RECURRENCE AFTER INITIAL RESPONSE TO UGN-101 INDUCTION IN EXPANDED SETTINGS

A novel technique for contained aspiration and irrigation of priapism.  JOURNAL OF SEXUAL MEDICINE.  21:192-194.

First analysis of the safety and efficacy of UGN-101 in the treatment of ureteral tumors.  UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS.  42.

Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes

The ablative effect of mitomycin reverse thermal gel: Expanding the role for nephron preservation therapy in low grade upper tract urothelial carcinoma.  UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS.  41.

Efficacy and Safety of Mitomycin Gel (UGN-101) as an Adjuvant Therapy After Complete Endoscopic Management of Upper Tract Urothelial Carcinoma.  JOURNAL OF UROLOGY.  209:872-881.

Early experience with UGN-101 for the treatment of upper tract urothelial cancer-A multicenter evaluation of practice patterns and outcomes.  UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS.  41.

PD24-07 FIRST ANALYSIS OF THE SAFETY AND EFFICACY OF UGN-101 IN THE TREATMENT OF URETERAL TUMORS

PD46-08 EFFICACY AND SAFETY OF MITOMYCIN GEL (UGN-101) AS AN ADJUVANT THERAPY AFTER COMPLETE ENDOSCOPIC MANAGEMENT OF UPPER TRACT UROTHELIAL CARCINOMA

Understanding Prescribing Differences Between Urologists and Medical Oncologists in the Management of Advanced Prostate Cancer.  UROLOGY PRACTICE.  10.

Clinicopathological analysis of recurrence and progression of low-grade papillary urothelial carcinoma of the urinary bladder: Predicting the outcome.  ANNALS OF DIAGNOSTIC PATHOLOGY.  61.

Variations in Opioid Use Following Robotic Radical Prostatectomy in South Florida.  JOURNAL OF ENDOUROLOGY.  36:1532-1537.

The Role of Health Literacy in Prostate Cancer Screening.  UROLOGY.  163:112-118.

MP28-06 THE ASSOCIATION OF ANXIETY IN YOUNGER VS OLDER MEN WITH BENIGN PROSTATIC HYPERPLASIA

The Association Between Race and 5-year Survival in Patients With Clear Cell Renal Cell Carcinoma: A Cohort Study.  UROLOGY.  148:185-191.

Trends in Positioning for Robotic Prostatectomy: Results From a Survey of the Endourological Society

Association Between Race and 5-Year Survival in Patients With Clear-Cell-Renal-Cell-Carcinoma.  ANNALS OF EPIDEMIOLOGY.  49:75.

MP27-08 URINARY EXOSOME TEST AND MP-MRI FOR PROSTATE CANCER SCREENING: BALANCING COSTS AND BENEFITS

Etiology of priapism in the community: local factors can help guide prevention and savings

Does Health Insurance Modify the Association Between Race and Cancer-Specific Survival in Patients with Urinary Bladder Malignancy in the US?

Barriers to Neoadjuvant Chemotherapy before Radical Cystectomy at a Single Referral Center in South Florida.  UROLOGY PRACTICE.  6:317-321.

Insurance status as a modifier of the association between race and stage of prostate cancer diagnosis in Florida during 1995 and 2013.  CANCER EPIDEMIOLOGY.  59:104-108.

MP71-11 NEOADJUVANT CHEMOTHERAPY UTILIZATION IN SOUTH FLORIDA: A SINGLE-INSTITUTION REPORT OF BARRIERS TO RECEIPT OF NEOADJUVANT CHEMOTHERAPY

Alexis Wound Retractor for Radical Cystectomy: A Safe and Effective Method for Retraction

Urology Patients and the Internet: Socioeconomic Status and Language Skills Significantly Impact Use.  UROLOGY PRACTICE.  2:317-320.

Reducing Robotic Prostatectomy Costs by Minimizing Instrumentation.  JOURNAL OF ENDOUROLOGY.  29:556-560.

PD2-08 HIGH RISK OF PRIAPISM IN RECREATIONAL INTRACAVERNOSAL DRUG ABUSERS

Lessons learned from routine intraoperative ureteral margin frozen sections during radical cystectomy.  UROLOGY PRACTICE.  2:90-95.

Robot-Assisted Nephroureterectomy and Bladder Cuff Excision Without Patient or Robot Repositioning: Description of Modified Port Placement and Technique.  JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES.  25.

Robot-Assisted Nephroureterectomy and Bladder Cuff Excision Without Patient or Robot Repositioning: Description of Modified Port Placement and Technique.  JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES.  24:647-650.

An Adult Case of Paratesticular Spindle Cell Rhabdomyosarcoma

Reluctance of general practitioners to refer gross hematuria patients to urology

2217 REDUCING RADIATION EXPOSURE WHEN IMAGING PATIENTS WITH HEMATURIA

The Optimal Diagnosis of Urothelial Carcinoma of the Bladder

1026 WHAT DO MOST PATIENTS WITH BLADDER CANCER ULTIMATELY SUCCOMB TO: A 25-YEAR FOLLOW-UP OF A SINGLE INSTITUTION'S BLADDER CANCER REGISTRY (1980-2004)

Survival Disparities Among African American Women With Invasive Bladder Cancer in Florida.  CANCER.  115:4196-4209.

Bladder Cancer Clusters in Florida: Identifying Populations at Risk.  JOURNAL OF UROLOGY.  182:46-50.

Radiation Therapy for Prostate Cancer Increases Subsequent Risk of Bladder and Rectal Cancer: A Population Based Cohort Study.  JOURNAL OF UROLOGY.  180:2005-2009.

Factors affecting erectile function after radical retropubic prostatectomy: results from 1620 consecutive patients.  BJU INTERNATIONAL.  101:833-836.

Modified Pfannenstiel approach for radical retropubic prostatectomy: a 3-year experience

Delayed local recurrence following radiation therapy for muscle-invasive bladder cancer emphasizing the need for lifelong surveillance: A case report

Florida bladder cancer trends 1981 to 2004: Minimal progress in decreasing advanced disease.  JOURNAL OF UROLOGY.  179:491-495.

Hemospermia following transrectal ultrasound-guided prostate biopsy: A prospective study

Intraoperative cell salvage during radical cystectomy does not affect long-term survival.  UROLOGY.  69:881-884.

1665: Lymphovascular Invasion in Bladder Cancer - Is it an Important Prognostic Indicator?

572: Radical Cystectomy in Octogenarian: Is Routine Post Operative Intensive Care Monitoring Necessary?

Does body mass index affect outcome after reconstruction of orthotopic neobladder?.  UROLOGY.  69:475-478.

Lack of progress in early diagnosis of bladder cancer.  UROLOGY.  69:270-274.

A pelvic drain can often be avoided after radical retropubic prostatectomy - An update in 552 cases

Are patients aware of the association between smoking and bladder cancer?.  JOURNAL OF UROLOGY.  176:2405-2408.

Concurrent radical retropubic prostatectomy and Lichtenstein inguinal hernia repair through a single modified Pfannenstiel incision: a 3-year experience.  BJU INTERNATIONAL.  98:341-344.

The Role of the Surgeon and Transurethral Resection in the Treatment of Superficial Bladder Cancer

1607: Concurrent Inguinal Hernia Repair and Radical Retropubic Prostatectomy through a Single Modified Pfannenstiel Incision: 3 Year Experience

Radical cystectomy after bacillus Calmette-Gumn for high-risk Ta,T1, and carcinoma in situ: Defining the risk of initial bladder preservation.  UROLOGY.  67:737-741.

Bladder wall abscess following midurethral sling procedure.  INTERNATIONAL UROGYNECOLOGY JOURNAL.  17:180-181.

Orthotopic ileal neobladder reconstruction for bladder cancer: Is adjuvant chemotherapy safe?

The role of the surgeon and transurethral resection in the treatment of superficial bladder cancer.  SCIENTIFIC WORLD JOURNAL.  6:2626-2631.

Transitional cell carcinoma associated with marijuana: Case report and review of the literature.  UROLOGY.  67:EE5-EE6.

Transurethral bladder tumor resection: Intraoperative and postoperative complications in a residency setting.  JOURNAL OF UROLOGY.  174:2307-2309.

Cystoprostatectomy and orthotopic ileal neobladder reconstruction for management of bacille Calmette Guerin-induced bladder contractures.  UROLOGY.  65:909-912.

Intraoperative cell salvage during radical prostatectomy is not associated with greater biochemical recurrence rate.  UROLOGY.  65:730-734.

Evaluation of analgesic requirements and postoperative recovery after radical retropubic prostatectomy using long-acting spinal anesthesia.  UROLOGY.  65:509-512.

Neither α-blocker therapy nor cystography is required before early catheter removal after radical prostatectomy.  BJU INTERNATIONAL.  95:323-325.

Robot-assisted laparoscopic partial nephrectomy..  JSLS-JOURNAL OF THE SOCIETY OF LAPAROENDOSCOPIC SURGEONS.  9:83-86.

How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk?.  CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION.  13:1765-1771.

Urethral recurrence after cystoprostatectomy: Implications for urinary diversion and monitoring.  UROLOGY.  64:950-954.

Induction of anoikis by doxazosin in prostate cancer cells is associated with activation of caspase-3 and a reduction of focal adhesion kinase

How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk?.  CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION.  13:1765-1771.

Intraoperative cell salvage during radical prostatectomy: A safe technique for Jehovah's witnesses

The role of partial nephrectomy for renal cell carcinoma in contemporary practice

Hand-assisted laparoscopy for large renal specimens: A multi-institutional study.  UROLOGY.  61:78-82.

Prospective comparison of hand-assisted laparoscopic devices.  UROLOGY.  59:668-672.

INTRAOPERATIVE AND POSTOPERATIVE COMPLICATIONS OF RADICAL RETROPUBIC PROSTATECTOMY IN A CONSECUTIVE SERIES OF 1,000 CASES

Intraoperative and postoperative complications of radical retropubic prostatectomy in a consecutive series of 1,000 cases.  JOURNAL OF UROLOGY.  166:1729-1733.

Early removal of urinary catheter after radical retropubic prostatectomy is both feasible and desirable.  UROLOGY.  58:425-429.

Comparison of two different doses of preoperative recombinant erythropoietin in men undergoing radical retropubic prostatectomy.  UROLOGY.  57:737-741.

TOTAL VAGINAL PROLAPSE WITH MULTIPLE VESICAL CALCULI AFTER HYSTERECTOMY

Total vaginal prolapse with multiple vesical calculi after hysterectomy.  JOURNAL OF UROLOGY.  159:983-983.

Effect of terazosin on prostatism in men with normal and abnormal peak urinary flow rates.  UROLOGY.  49:476-480.

Total prostate and transition zone volumes, and transition zone index are poorly correlated with objective measures of clinical benign prostatic hyperplasia.  JOURNAL OF UROLOGY.  158:85-88.

Are patients with hematuria appropriately referred to Urology? A multi-institutional questionnaire based survey.  UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS.  28:500-503.

Presentation and Outcome Following Radical Cystectomy in Hispanics with Bladder Cancer

Chapter 7 PHARMACOLOGIC COMPLICATIONS.  85-93.

Pharmacologic complications.  85-93.

Pharmacologic complications.  85-93.

Surgical management: Cystectomy and urinary diversion.  348-360.

Preparation for Prostate Biopsy.  97-104.

Future directions in nephron-sparing surgery.  147-148.

ASSOCIATION BETWEEN SEXUAL ORIENTATION AND PROSTATE CANCER SCREENING.  JOURNAL OF SEXUAL MEDICINE. S91-S91.

NEOADJUVANT CHEMOTHERAPY UTILIZATION IN SOUTH FLORIDA: A SINGLE-INSTITUTION REPORT OF BARRIERS TO RECEIPT OF NEOADJUVANT CHEMOTHERAPY.  JOURNAL OF UROLOGY. E947-E947.

SALVAGE ROBOTIC PARTIAL NEPHRECTOMY AFTER CRYOABLATION.  JOURNAL OF UROLOGY. E290-E290.

A RETROSPECTIVE ANALYSIS OF RISK FACTORS FOR IPP RESERVOIR ENTRY INTO THE PERITONEUM AFTER POSTERIOR TO TRANSVERSALIS FASCIA PLACEMENT.  JOURNAL OF SEXUAL MEDICINE. S106-S106.

ALEXIS WOUND PROTECTOR/RETRACTOR REDUCES WOUND INFECTION DURING RADICAL CYSTECTOMY AND URINARY DIVERSION.  JOURNAL OF UROLOGY. E267-E267.

MINIMIZING WARM ISCHEMIA DURING ROBOTIC ASSISTED PARTIAL NEPHRECTOMY.  JOURNAL OF UROLOGY. E617-E617.

Florida state bladder cancer clusters: Identification of populations at risk.  JOURNAL OF UROLOGY. 321-322.

Outcomes of PTO at radical cystectomy without neoadjuvant therapy.  JOURNAL OF UROLOGY. 552-552.

Prostate radiotherapy. What is the contemporary risk of bladder and rectal carcinoma?.  JOURNAL OF UROLOGY. 322-322.

Does the body mass index affect the outcome following reconstruction of orthotopic neobladder?.  JOURNAL OF UROLOGY. 64-64.

Evaluation and work-up of hematuria among primary care physicians in Miami-Dade county: An anonymous questionnaire-based survey.  JOURNAL OF UROLOGY. 357-357.

Factors affecting potency following radical retropubic prostatectomy: Results from 1620 consecutive patients.  JOURNAL OF UROLOGY. 186-186.

Lymphovascular invasion in bladder cancer - Is it an important prognostic indicator?.  JOURNAL OF UROLOGY. 552-552.

Radical cystectomy in octogenarian: Is routine post operative intensive care monitoring necessary?.  JOURNAL OF UROLOGY. 191-191.

Management of stage T1 tumors of the bladder: International consensus panel.  UROLOGY. 108-125.

Radical cystectomy after BCG: Are we waiting toolong?.  JOURNAL OF UROLOGY. 304-304.

Re: The Causal Role of Cigarette Smoking in Bladder Cancer Initiation and Progression, and the Role of Urologists in Smoking Cessation.  JOURNAL OF UROLOGY. 2713-2713.

Re: Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?.  JOURNAL OF UROLOGY. 352-352.

Reply to Tine!Hajdinjak and Nadja!Kokalj-Vokac's letter to the Editor re:: Re:: Mecedes!Marin-Aguilera, Lourdes!Mengual, Maria Jose!Ribal et al.: Utility of fluorescence in situ hybridization as a non-invasive technique in the diagnosis of upper urinary tract urothelial carcinoma.: Eur Urol 2007;51:409-15 and Alan M.!Nieder, Mark S.!Soloway and Harry W.!Herr.: Should we abandon the FISH test?: Eur Urol 2007;51:1469-71.: Eur Urol 2007;52:287-9.  290-290.

AUTHOR REPLY.  UROLOGY. 118.

Editorial Comment.  JOURNAL OF UROLOGY. 1284.

Editorial Comment.  UROLOGY. 177.

Editorial comment.  654-655.

Ethnic disparities in clinical trials for FDA-approved drugs in prostate cancer: A post-COVID-19 era analysis (2020-2024)..  JOURNAL OF CLINICAL ONCOLOGY.

Ethnic disparities in clinical trials for FDA-approved drugs in renal cell carcinoma: An analysis in the post-COVID-19-era (2020-2024)..  JOURNAL OF CLINICAL ONCOLOGY.

Corrigendum to “Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes” [Eur. Urol. Focus (2023)] (European Urology Focus (2023) 9(6) (1052–1058), (S2405456923001232), (10.1016/j.euf.2023.05.012)).  211.

Bladder and Kidney Cancer Diagnosis and Survival Increase With Medicare Eligibility at Age 65 Reply.  UROLOGY PRACTICE. 98-98.

A Systematic Review and Scoping Analysis of Smoking Cessation after a Urological Cancer Diagnosis COMMENTS.  JOURNAL OF UROLOGY. 1284-1284.

The Association Between Race and 5-year Survival in Patients With Clear Cell Renal Cell Carcinoma: A Cohort Study EDITORIAL COMMENT AUTHOR REPLY.  UROLOGY. 190-191.

EDITORIAL COMMENT.  UROLOGY. 106-106.

EDITORIAL COMMENT.  UROLOGY. 117-117.

Variation in Testosterone Levels and Health-related Quality of Life in Men Diagnosed With Prostate Cancer on Active Surveillance.  UROLOGY. 187-187.

Giant Fungating Basal Cell Carcinoma of the Scrotum.  UROLOGY. E1-E2.

Omissions in Urology Residency Training Regarding Sexual Dysfunction Subsequent to Prostate Cancer Treatment: Identifying a Need EDITORIAL COMMENT.  UROLOGY. 25-25.

Effect of Tamsulosin in Lower Urinary Tract Symptom Patients With Metabolic Syndrome EDITORIAL COMMENT.  UROLOGY. 141-141.

Tamsulosin Treatment Affecting Patient-reported Outcomes in Benign Prostatic Hyperplasia-associated Depressive Symptoms EDITORIAL COMMENT.  UROLOGY. 177-177.

Expert Witness Testimony in Urology Malpractice Litigation EDITORIAL COMMENT.  UROLOGY. 708-708.

Trends in the Utilization of Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Results From the National Cancer Database EDITORIAL COMMENT.  UROLOGY. 80-80.

Audio and Visual Analysis of Urologic Laparoscopic and Robotic Skills: Objective Criteria for Surgical Skill Evaluation COMMENT.  UROLOGY. 1282-1282.

Influence of Urinary Tract Instrumentation and Inflammation on the Performance of Urine Markers for the Detection of Bladder Cancer EDITORIAL COMMENT.  UROLOGY. 625-625.

Reluctance of general practitioners to refer gross hematuria patients to urology.  102-102.

C-Index is Associated With Functional Outcomes After Laparoscopic Partial Nephrectomy EDITORIAL COMMENT.  JOURNAL OF UROLOGY. 2263-2263.

Should Patients With Primary Upper Urinary Tract Cancer Receive Prophylactic Intravesical Chemotherapy After Nephroureterectomy? EDITORIAL COMMENT.  JOURNAL OF UROLOGY. 61-61.

Cardiac History and Risk of Post-cystectomy Cardiac Complications EDITORIAL COMMENT.  UROLOGY. 1089-1089.

Urinary Collecting System Invasion is an Independent Prognostic Factor of Organ Confined Renal Cell Carcinoma Comment.  JOURNAL OF UROLOGY. 859-859.

The Prognostic Impact of Comorbidities on Renal Cancer, 1995 to 2006: A Danish Population Based Study EDITORIAL COMMENT.  JOURNAL OF UROLOGY. 40-40.

It's Not a Radical Prostatectomy, It's a Total Prostatectomy.  715-716.

Commentary on association of clinical prostate and bladder cancers.  JOURNAL OF UROLOGY. S6-S6.

Outcome after radical cystectomy with limited or extended pelvic lymph node dissection - Comment.  JOURNAL OF UROLOGY. 878-878.

Editorial comment.  JOURNAL OF UROLOGY. 2336-2336.

Management of low grade papillary bladder tumors - Comment.  JOURNAL OF UROLOGY. 1205-1205.

Should we abandon the FISH test?.  1469-1471.

We are not yet ready to abandon cystoscopy.  130-131.

Eliminate the term "superficial" bladder cancer.  JOURNAL OF UROLOGY. 417-418.

Upper tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: incidence and risk factors.  BJU INTERNATIONAL. 785-789.

Overcoming Drug Resistance in Advanced Prostate Cancer by Drug Repurposing

A Comparison Between AMS 700 and Coloplast Titan: A Systematic Literature Review

The Single Wire Ureteral Access Sheath, Both Safe and Economical

Neobladder reconstruction following radical cystoprostatectomy for invasive bladder cancer.  41-54.

Genetic counseling for prostate cancer risk.  169-176.